Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers
Clinical trial NCT02655822 · COMPLETED
Trial details
- NCT number
- NCT02655822
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2021-06-01
- Enrollment
- 502
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.